Effect of oxaliplatin in elderly colon cancer patients with pathological T4 and/or N2 disease: a multicenter, propensity score-matched analysis.
Tetsuro TominagaTakashi NonakaShosaburo OyamaToshio ShiraishiHiroaki TakeshitaMakoto HisanagaHidetoshi FukuokaAkiko FukudaYorihisa SumidaShintaro HashimotoKazuo ToKenji TanakaTerumitsu SawaiTakeshi NagayasuPublished in: International journal of colorectal disease (2022)
The selected old colon cancer patients with a high risk of recurrence gained an additional benefit with respect to prognosis from FU + oxaliplatin as AC.
Keyphrases